Omalizumab (Xolair)

omalizumab · Genentech (Roche)

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Omalizumab (Xolair), covering 2011-08-01 to 2025-10-23. Get the full timeline:

Most recent: Clinical Trial Update: EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients [Phase 4]